CENTOGENE Reports Third-Quarter 2020 Financial Results and Increases Full Year Guidance
Press release content from Globe Newswire. The AP news staff was not involved in its creation. CENTOGENE Reports Third-Quarter 2020 Financial Results and Increases Full Year Guidance CENTOGENE GmbHDecember 16, 2020 GMT CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today provided an update on its corpo...